Gastric mucosal plasminogen activators in Helicobacter pylori infection. 1996

J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
Department of Gastroenterology and Hepatology, University Hospital Leiden, The Netherlands.

Long-term H. pylori associated gastritis is recognized as a pathogenic factor in gastric carcinogenesis. In gastric carcinomas the amount and activity of the tissue-type plasminogen activator (t-PA) have been reported to be decreased, whereas those of the urokinase-type plasminogen activator (u-PA) were increased, contributing to the neoplastic and invasive process. The present study was performed to determine t-PA and u-PA levels and activity in gastric mucosa from 102 patients and to investigate whether these levels are influenced by H. pylori infection. The antigen concentration and activity of t-PA and u-PA in corpus mucosa were low (P < 0.001) compared with those in antral mucosa, although for the u-PA activity this did not reach statistical significance. In H. pylori-associated antral gastritis the mucosal t-PA antigen concentration and activity were found to be decreased (P < 0.001) compared with normal mucosa, whereas in H. pylori-associated pangastritis the corpus t-PA levels were not affected. The antigen concentration and activity of u-PA were found to be significantly (P < 0.005) increased, both in H. pylori-associated gastritis of antrum and corpus mucosa. Levels of u-PA in histologically normal corpus mucosa of patients with an H. pylori-associated antral gastritis were also found to be increased (P < 0.05). In conclusion, the alterations in the plasminogen activator profile found in H. pylori-associated gastritis, ie, a decrease in t-PA and an increase in u-PA, show a similar tendency as the previously found alterations in gastric carcinomas, which provides additional support for the possible involvement of H. pylori-associated gastritis in the pathogenesis of gastric carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011706 Pyloric Antrum The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS). Antrum, Pyloric,Gastric Antrum,Antrum, Gastric,Antrums, Gastric,Antrums, Pyloric,Gastric Antrums,Pyloric Antrums
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
April 1996, Gut,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
February 2002, Nihon rinsho. Japanese journal of clinical medicine,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
April 1997, Journal of gastroenterology,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
July 2005, Revista espanola de enfermedades digestivas,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
January 2022, Infection and drug resistance,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
January 2000, International journal of clinical & laboratory research,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
April 2007, Pediatrics international : official journal of the Japan Pediatric Society,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
May 2014, Zhonghua bing li xue za zhi = Chinese journal of pathology,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
January 2018, Infectious disorders drug targets,
J M Götz, and Y Vergouwe, and H W Verspaget, and I Biemond, and C F Sier, and C B Lamers, and R A Veenendaal
January 2001, Intensive care medicine,
Copied contents to your clipboard!